The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ANIP FINANCIAL STATEMENTS

ANI Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

ANIPANI Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M1 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue978.4 M $Gross Profit472.3 M $ · 48%Operating Income150.2 M $ · 15%Pre-tax Income142.6 M $ · 15%Net Income to Owners105.8 M $ · 11%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue978.4 M $+30.9%
Gross Profit472.3 M $+3.5%
Operating Income150.2 M $+888.7%
EBITDA248.6 M $+179.2%
Net Income to Owners105.8 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.5 B
  • Equity597.2 M $40%
  • Current Liabilities283.7 M $19%
  • Long-term Liabilities613.2 M $41%

Key Figures

YoY change
Total Assets1.5 B $+11.3%
Total Liabilities896.9 M $+1.8%
Total Equity597.2 M $+29.4%
Cash & ST Investments360.2 M $+61.2%
Total Debt330.3 M $-46.9%
Net Debt-29.9 M $-107.4%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0100 M200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0100 M189.5 M $Operating-21.9 M $Investing-24.6 M $Financing143 M $Net Change

Key Figures

YoY change
Operating Cash Flow189.5 M $+36.2%
Capital Expenditures52.7 M $+54.7%
Free Cash Flow159.4 M $+51.7%
Dividends Paid-344 K $-142.4%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ANIP

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.